‌

US Patent 10751413 Anti-pro/latent-Myostatin antibodies and uses thereof

Patent 10751413 was granted and assigned to Scholar Rock on August, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Scholar Rock

Current Assignee

Scholar Rock

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107514130

Date of Patent

August 25, 2020

Patent Application Number

157603930

Date Filed

September 15, 2016

Patent Citations

‌

US Patent 10287345 Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies

‌

US Patent 10307480 Anti-pro/latent-myostatin antibodies and uses thereof

Patent Citations Received

‌

US Patent 12006359 Methods for altering body composition by administering anti-pro/latent myostatin antibodies

‌

US Patent 11439704 Methods for using anti-myostatin antibodies

‌

US Patent 11925683 Compositions for making and using anti-Myostatin antibodies

Patent Primary Examiner

‌

Zachary C Howard

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10751413 Anti-pro/latent-Myostatin antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API